Bayesian Capital Management’s Keurig Dr Pepper KDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-119,700
Closed -$3.05M 334
2025
Q3
$3.05M Buy
+119,700
New +$3.75M 0.62% 26
2025
Q2
Sell
-85,900
Closed -$2.94M 723
2025
Q1
$2.94M Buy
85,900
+46,100
+116% +$1.5M 0.49% 50
2024
Q4
$1.28M Buy
+39,800
New +$1.35M 0.16% 186
2024
Q3
Sell
-85,200
Closed -$2.85M 874
2024
Q2
$2.85M Buy
85,200
+77,900
+1,067% +$2.58M 0.33% 73
2024
Q1
$224K Buy
+7,300
New +$225K 0.02% 632
2021
Q1
Sell
-17,953
Closed -$574K 619
2020
Q4
$574K Buy
17,953
+1,553
+9% +$46K 0.15% 193
2020
Q3
$453K Sell
16,400
-12,400
-43% -$363K 0.11% 243
2020
Q2
$818K Sell
28,800
-43,600
-60% -$1.18M 0.18% 162
2020
Q1
$1.76M Buy
72,400
+25,300
+54% +$682K 0.38% 49
2019
Q4
$1.36M Buy
47,100
+29,900
+174% +$859K 0.23% 117
2019
Q3
$470K Buy
+17,200
New +$480K 0.09% 286
2019
Q1
Sell
-8,300
Closed -$213K 665
2018
Q4
$213K Buy
+8,300
New +$211K 0.04% 503
2018
Q3
Sell
-1,800
Closed -$220K 715
2018
Q2
$220K Buy
+1,800
New +$216K 0.05% 496

Other funds holding KDP

Bayesian Capital Management's KDP Position: Q4 2025 in Review

Bayesian Capital Management sold out of Keurig Dr Pepper (KDP) in Q4 2025, closing a stake of 119,700 shares — an estimated $3.05M sold.

Bayesian Capital Management first reported a position in KDP in Q2 2018 and held it in 13 quarters. The position peaked at $3.05M in Q3 2025. 851 funds tracked by Wall St. Rank hold KDP as of Q4 2025.

  • Bayesian Capital Management reported no remaining Keurig Dr Pepper position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 119,700 Keurig Dr Pepper shares in Q4 2025, an estimated $3.05M.
  • Bayesian Capital Management first reported a position in Keurig Dr Pepper in Q2 2018 and held it in 13 quarters.
  • Bayesian Capital Management's Keurig Dr Pepper position peaked at $3.05M in Q3 2025.
  • 851 funds tracked by Wall St. Rank held Keurig Dr Pepper as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.